BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32068651)

  • 1. Acute Megakaryoblastic Leukemia Leading to the Diagnosis of Germline Trisomy 21 Mosaicism.
    Savla D; Del Campo M; Masser-Frye D; Kuo DJ
    J Pediatr Hematol Oncol; 2020 May; 42(4):299-301. PubMed ID: 32068651
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute megakaryoblastic leukemia and clonal trisomy 21 in a phenotypically normal infant.
    Arico M
    Blood; 1991 Jun; 77(11):2542-3. PubMed ID: 1828181
    [No Abstract]   [Full Text] [Related]  

  • 3. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
    Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome.
    Ma SK; Lee AC; Wan TS; Lam CK; Chan LC
    Leukemia; 1999 Mar; 13(3):491-2. PubMed ID: 10086746
    [No Abstract]   [Full Text] [Related]  

  • 6. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21.
    Bonometti A; Lobascio G; Boveri E; Cesari S; Lecca M; Arossa A; Spinillo A; Errichiello E; Paulli M
    Leuk Lymphoma; 2021 Sep; 62(9):2276-2279. PubMed ID: 33783296
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome.
    Doyle JJ; Thorner P; Poon A; Tanswell K; Kamel-Reid S; Zipursky A
    Leuk Lymphoma; 1995 Apr; 17(3-4):345-50. PubMed ID: 8580807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of Acute Megakaryoblastic Leukemia Associated with a GATA-1 Mutation Mimicking the Eruption of Transient Myeloproliferative Disorder.
    Boos MD; Wine Lee L; Freedman JL; Novoa RA; Chu EY; Perman MJ
    Pediatr Dermatol; 2015; 32(5):e204-7. PubMed ID: 26205501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
    Azad VF; Mehrvar A; Mehrvar N
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
    Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute megakaryoblastic leukemia in early childhood; report of two cases].
    Morioka Y; Sugimoto T; Imashuku S; Matsumura T; Todo S; Nagai T; Koike T
    Rinsho Ketsueki; 1988 Feb; 29(2):214-20. PubMed ID: 2968473
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
    Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
    Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
    Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the International System for Human Cytogenetic Nomenclature (ISCN).
    Gonzalez Garcia JR; Meza-Espinoza JP
    Blood; 2006 Dec; 108(12):3952-3; author reply 3953. PubMed ID: 17114573
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
    Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
    Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.
    Sandoval C; Pine SR; Guo Q; Sastry S; Stewart J; Kronn D; Jayabose S
    Pediatr Blood Cancer; 2005 Jan; 44(1):85-91. PubMed ID: 15390279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
    Kudo K; Hama A; Kojima S; Ishii R; Morimoto A; Bessho F; Sunami S; Kobayashi N; Kinoshita A; Okimoto Y; Tawa A; Tsukimoto I
    Int J Hematol; 2010 May; 91(4):630-5. PubMed ID: 20237876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.